nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Access to medicines for CVD—what's the trade-off?
|
The Lancet Diabetes & Endocrinology, |
|
2016 |
4 |
3 |
p. 187 |
artikel |
2 |
An artistic awakening
|
Thorley, Jennifer |
|
2016 |
4 |
3 |
p. 209 |
artikel |
3 |
Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes
|
Muskiet, Marcel H A |
|
2016 |
4 |
3 |
p. 188-189 |
artikel |
4 |
Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study
|
Weber, Michael A |
|
2016 |
4 |
3 |
p. 211-220 |
artikel |
5 |
Causes, diagnosis, and treatment of central precocious puberty
|
Latronico, Ana Claudia |
|
2016 |
4 |
3 |
p. 265-274 |
artikel |
6 |
Closed-loop control in type 1 diabetes
|
Buckingham, Bruce |
|
2016 |
4 |
3 |
p. 191-193 |
artikel |
7 |
Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial
|
Xavier, Denis |
|
2016 |
4 |
3 |
p. 244-253 |
artikel |
8 |
Community health workers for recovery from acute coronary syndrome
|
Balcazar, Hector G |
|
2016 |
4 |
3 |
p. 194-195 |
artikel |
9 |
Constraints and challenges in access to insulin: a global perspective
|
Beran, David |
|
2016 |
4 |
3 |
p. 275-285 |
artikel |
10 |
Correction to Lancet Diabetes Endocrinol 2015; published online Nov 24. http://dx.doi.org/10.1016/S2213-8587(15)00417-9
|
|
|
2016 |
4 |
3 |
p. e3 |
artikel |
11 |
David Beran: the battle for 100% access to insulin
|
Morgan, Jules |
|
2016 |
4 |
3 |
p. 210 |
artikel |
12 |
Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial
|
Russell, Steven J |
|
2016 |
4 |
3 |
p. 233-243 |
artikel |
13 |
Developing equity in capacity of paediatric endocrinology subspecialists worldwide
|
Odundo, Gordon Otieno |
|
2016 |
4 |
3 |
p. 204-205 |
artikel |
14 |
Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial
|
Dejgaard, Thomas Fremming |
|
2016 |
4 |
3 |
p. 221-232 |
artikel |
15 |
Innovation in capacity building of primary-care physicians in diabetes management in India: a new slant in medical education
|
Bhalla, Sandeep |
|
2016 |
4 |
3 |
p. 200-202 |
artikel |
16 |
Invasive phaeochromocytoma presenting as a right atrial mass
|
Loper, Hillary |
|
2016 |
4 |
3 |
p. 286 |
artikel |
17 |
Liberating data: the crucial weapon in the fight against NCDs
|
Davies, Justine |
|
2016 |
4 |
3 |
p. 197-198 |
artikel |
18 |
Psychosocial dimensions of early-onset puberty and its treatment
|
Roberts, Celia |
|
2016 |
4 |
3 |
p. 195-197 |
artikel |
19 |
Pubertal development and regulation
|
Abreu, Ana Paula |
|
2016 |
4 |
3 |
p. 254-264 |
artikel |
20 |
Research in brief
|
Kang, Seema |
|
2016 |
4 |
3 |
p. 206 |
artikel |
21 |
Self-determining legal gender: transgender right, or wrong?
|
Morgan, Jules |
|
2016 |
4 |
3 |
p. 207-208 |
artikel |
22 |
Self-harm and suicide after bariatric surgery: time for action
|
Dixon, John B |
|
2016 |
4 |
3 |
p. 199-200 |
artikel |
23 |
The 2015 Endocrinology in Focus winners
|
Bennet, Neil |
|
2016 |
4 |
3 |
p. 202-203 |
artikel |
24 |
Use of liraglutide in type 1 diabetes: implications for management
|
Simmons, David |
|
2016 |
4 |
3 |
p. 190-191 |
artikel |